Dallas, TX & Brentwood, TN – [Current Date, e.g., October 26, 2023] – In a transformative move poised to redefine the landscape of patient care for individuals requiring mobility and rehabilitative solutions, Hanger Inc., a leading provider of orthotic and prosthetic (O&P) patient care services, has announced its intent to acquire Numotion, a prominent provider of complex rehabilitation technology (CRT) and mobility products and services. This strategic combination will culminate in the formation of Hanger Numotion, a formidable North American platform dedicated to delivering comprehensive solutions across O&P, CRT, and general mobility services. The newly formed entity is projected to serve over 1.5 million patients annually across the United States and Canada, marking a significant milestone in the industry.
The transaction, structured as a cash acquisition of Numotion by Hanger, is anticipated to close in the fourth quarter of 2026, subject to customary closing conditions. Upon completion, the combined enterprise will be controlled by Patient Square Capital, a healthcare-focused private equity firm, signaling a strategic vision for long-term growth and enhanced patient outcomes. Mike Swinford, the current CEO of Numotion, is slated to assume the leadership role as CEO of Hanger Numotion, bringing his extensive experience in scaling and diversifying mobility services to the helm of the integrated organization.
Main Facts of the Landmark Acquisition
The impending merger of Hanger Inc. and Numotion represents a pivotal moment for individuals relying on specialized mobility and rehabilitative care. At its core, this alliance seeks to create an unparalleled continuum of care, addressing a broader spectrum of patient needs under a single, integrated umbrella.
Hanger Inc., with its deep-rooted history and extensive network, has long been a vanguard in the orthotics and prosthetics sector. Operating 925 O&P clinics across the U.S., Hanger provides custom-designed devices that restore mobility and independence to patients facing limb loss or musculoskeletal challenges. Its expertise encompasses everything from advanced prosthetic limbs and orthotic braces to post-surgical rehabilitation and ongoing support.
Numotion, a portfolio company of AEA Investors (AEA) and with longstanding support from LLR, has established itself as the premier provider of complex rehabilitation technology and mobility products. With over 200 locations spanning both the U.S. and Canada, Numotion specializes in custom-configured mobility solutions, including power wheelchairs, manual wheelchairs, adaptive seating, and other assistive technologies critical for individuals with complex neurological or orthopedic conditions. These devices are often life-altering, enabling patients to navigate their daily lives with greater autonomy and dignity.
The fusion of these two industry titans will result in Hanger Numotion, a combined entity designed to leverage complementary capabilities. While Hanger will bring its O&P prowess, Numotion contributes its expertise in CRT and broader mobility solutions. This integration means that a patient who requires a prosthetic limb might also need a custom power wheelchair for optimal independence, and Hanger Numotion aims to provide both through a more streamlined and coordinated process.
Collectively, the new organization will command a formidable geographic footprint, encompassing more than 1,125 clinical and service locations across North America. This expansive network will serve an estimated 1.5 million patients annually, offering unprecedented access to specialized care. Despite the integration, both Hanger and Numotion will continue to operate under their existing, well-recognized brands, maintaining their respective clinical operations to ensure continuity of care and preserve established patient relationships.
The financial structure of the deal sees Hanger acquiring Numotion for cash. Crucially, the controlling interest in the combined entity will reside with Patient Square Capital. This strategic oversight from a healthcare-dedicated investment firm underscores a commitment to long-term growth, innovation, and patient-centric advancements.
Leadership for the new enterprise will be spearheaded by Mike Swinford, who has a proven track record of transformative leadership at Numotion since 2014. His appointment as CEO of Hanger Numotion signals a clear direction towards leveraging his experience in scaling and diversifying mobility services to guide the integrated company. Pete Stoy, the outgoing CEO of Hanger Inc., expressed strong confidence in Swinford’s ability to lead the combined organization, acknowledging his shared commitment to patients and employees. The anticipated closing in late 2026 provides a substantial window for regulatory approvals and meticulous planning to ensure a smooth transition and integration.
A Detailed Chronology of the Strategic Alliance
The formation of Hanger Numotion is not merely a transaction; it is the culmination of individual journeys of growth and strategic foresight by two market leaders, converging to address evolving patient needs and capitalize on synergistic opportunities.
Pre-Merger Landscape: Hanger’s Evolution
Hanger Inc. boasts a legacy stretching back over 160 years, rooted in a commitment to restoring mobility and independence through orthotics and prosthetics. Over the decades, Hanger has grown from pioneering efforts in prosthetic design to establishing a vast network of patient care clinics. Its journey has been characterized by continuous innovation in device technology, clinical methodologies, and patient support programs. More recently, under the leadership of Pete Stoy, who joined the company in 2020, Hanger embarked on a significant internal transformation. Stoy focused on building a stronger, more integrated national platform, investing substantially in its workforce, advanced technologies, and operational capabilities. This strategic overhaul positioned Hanger not only for sustained organic growth but also for strategic expansion, laying the groundwork for a partnership of this magnitude. The emphasis on integration and enhanced infrastructure under Stoy’s tenure made Hanger an even more attractive and capable partner for a large-scale merger.
Pre-Merger Landscape: Numotion’s Growth Trajectory
Numotion, while a more recent entrant compared to Hanger’s long history, has rapidly ascended to become the largest provider of complex rehabilitation technology in the U.S. and Canada. Its growth trajectory has been particularly steep under the guidance of Mike Swinford, who assumed the CEO role in 2014. Swinford’s leadership propelled Numotion into a mobility leader through sustained growth, aggressive expansion, and strategic diversification of its product and service offerings. The company’s focus on highly customized, medically necessary equipment for individuals with significant mobility limitations has cemented its reputation for specialized expertise. Backed by private equity firms AEA Investors and with longstanding support from LLR, Numotion expanded its geographic footprint and enhanced its service capabilities, becoming a critical link in the healthcare chain for patients requiring advanced mobility solutions. Swinford’s prior experience, including over two decades at GE, culminating as President and CEO of GE Healthcare Services, provided a robust foundation for scaling Numotion into the powerhouse it is today.
The Genesis of Hanger Numotion
The strategic rationale for combining Hanger and Numotion is rooted in the complementary nature of their services and a shared vision for holistic patient care. Discussions between the two entities likely originated from a recognition that many patients requiring O&P services also have needs best addressed by CRT, and vice-versa. For instance, an individual with a new prosthetic limb might also benefit from a specialized wheelchair for certain activities or for managing other concurrent conditions. Fragmented care, where patients must navigate multiple providers for different mobility solutions, can be cumbersome, inefficient, and potentially compromise overall outcomes.
The involvement of Patient Square Capital as the controlling entity suggests a carefully orchestrated strategy to create a dominant market player. Private equity firms often identify opportunities for consolidation to achieve greater scale, operational efficiencies, and market influence. Patient Square Capital, with its focus on healthcare, likely saw the immense potential in uniting two leaders to form a comprehensive mobility and rehabilitation platform. The due diligence process would have been extensive, assessing market dynamics, operational synergies, financial projections, and the potential for regulatory hurdles. The formal announcement of the acquisition for cash underscores the financial commitment and the strategic intent behind forming a new, integrated enterprise.
Post-Merger Operational Blueprint
A crucial aspect of the integration plan is the commitment that Hanger and Numotion will continue to serve customers under their existing, trusted brands. This decision is strategic, aiming to minimize disruption for patients and referring physicians who have established relationships and familiarity with each brand. Furthermore, the maintenance of their respective clinical operations initially suggests a phased integration approach, allowing for careful harmonization of processes, IT systems, and clinical protocols over time. This preserves the specialized expertise inherent in both O&P and CRT, ensuring that patients continue to receive the highest level of care specific to their needs. The long closing period until Q4 2026 provides ample time for the leadership teams, guided by Patient Square Capital, to develop a meticulous integration strategy that addresses operational, technological, and cultural aspects, ensuring a smooth transition into the combined Hanger Numotion entity.
Supporting Data and Market Context: A New Paradigm for Patient Care
The merger of Hanger and Numotion is not just an organizational restructuring; it represents a significant shift in the paradigm of how mobility and rehabilitation services are delivered, driven by market demand, technological advancements, and the strategic advantages of scale.
The Complementary Power of O&P and CRT
Orthotics and Prosthetics (O&P) focuses on the design, fabrication, and fitting of external medical devices to support or replace parts of the body. Prosthetics provide artificial limbs for individuals who have lost a limb due to trauma, disease, or congenital conditions, enabling them to regain function and participate in daily activities. Orthotics, conversely, involves braces and supports for various musculoskeletal conditions, aiming to correct deformities, reduce pain, or improve stability. This field requires highly specialized clinicians – prosthetists and orthotists – who work closely with patients over long periods, often for life.
Complex Rehabilitation Technology (CRT) caters to individuals with severe and permanent disabilities, often stemming from conditions like spinal cord injury, cerebral palsy, multiple sclerosis, or ALS. CRT involves custom-configured manual and power wheelchairs, adaptive seating systems, standing frames, and other mobility aids that are meticulously designed to meet the unique physical, functional, and environmental needs of each patient. These devices are crucial for independence, pressure injury prevention, respiratory support, and overall quality of life. CRT suppliers typically employ certified rehabilitation technology suppliers (CRTS) who collaborate with therapists and physicians.
The complementary nature of these two fields is profound. A patient with a lower limb amputation might require a sophisticated prosthetic limb from Hanger but also a custom power wheelchair from Numotion for longer distances or days when they cannot use their prosthesis. Historically, these patients would navigate separate providers, leading to potential gaps in communication, inconsistent equipment, and administrative burdens. The combined Hanger Numotion platform aims to create a "one-stop shop" experience, offering a holistic, integrated approach that simplifies the patient journey, coordinates care plans, and ensures seamless transitions between different types of mobility solutions. This integrated model is designed to improve clinical outcomes, enhance patient satisfaction, and reduce the fragmentation often seen in complex healthcare pathways.
Market Dominance and Geographic Reach
The sheer scale of Hanger Numotion is unprecedented in the North American mobility and rehabilitation market. With Hanger’s 925 U.S.-based O&P clinics and Numotion’s 200+ locations across North America, the combined entity will boast over 1,125 points of service. This extensive geographic coverage ensures broad access to care, reaching both urban centers and potentially more rural or underserved areas.
Serving over 1.5 million patients annually, Hanger Numotion will become a dominant force, creating significant competitive advantages. This scale can translate into enhanced purchasing power with suppliers, leading to cost efficiencies. It also positions the company as an attractive employer for top clinical talent, fostering an environment for professional development and knowledge sharing across a vast network. From a market perspective, this consolidation creates a formidable competitor, potentially influencing pricing, service standards, and innovation across the industry. Smaller, independent providers may face increased pressure to compete with the resources and reach of this new giant.
Investment in Innovation and Access to Care
One of the most compelling aspects of this merger is the potential for increased investment in innovation. Greater scale translates to greater financial resources that can be allocated to research and development (R&D). In the O&P and CRT sectors, innovation is continuous, involving advancements in materials science (e.g., lightweight composites, smart fabrics), biomechanics, robotics, artificial intelligence for adaptive control, and digital health solutions (e.g., telehealth, remote monitoring, 3D printing for custom devices). Hanger Numotion could accelerate the development and adoption of next-generation technologies, benefiting patients with more advanced, comfortable, and functional devices.
Furthermore, the combined scale and resources can significantly expand access to care. This could involve opening new clinics in underserved regions, increasing the number of certified clinicians, or developing specialized programs for specific patient populations. The ability to invest more in clinician training and development is also critical, ensuring that the workforce is equipped with the latest knowledge and skills to deliver cutting-edge care. This commitment to both technological advancement and human capital is essential for improving the quality and reach of mobility services.
The Role of Private Equity in Healthcare Consolidation
The involvement of Patient Square Capital as the controlling entity, and AEA Investors’ previous role with Numotion, highlights a broader trend of private equity investment in the healthcare services sector. Private equity firms are increasingly drawn to healthcare for its stability, growth potential (driven by aging populations and chronic diseases), and opportunities for operational improvements and consolidation.
These firms often provide the capital and strategic expertise needed to facilitate mergers, optimize operations, and drive aggressive growth strategies. By bringing together companies like Hanger and Numotion, private equity aims to create larger, more efficient, and more valuable enterprises. While critics sometimes raise concerns about potential impacts on patient care quality or affordability, proponents argue that private equity investment can inject much-needed capital for innovation, expand access, and improve the overall efficiency of healthcare delivery. In this instance, Patient Square Capital’s long-term vision for Hanger Numotion is clearly focused on leveraging synergies to build a market leader dedicated to enhancing patient mobility and independence.
Official Responses and Leadership Perspectives
The announcement of the Hanger Numotion merger was met with enthusiasm from the leadership of both companies, who articulated a shared vision for the future and underscored the transformative potential of their combined strengths.
Mike Swinford on Shared Vision and Future Direction
Mike Swinford, the seasoned executive who has successfully steered Numotion since 2014 and is poised to become the CEO of Hanger Numotion, articulated a clear and compelling vision for the combined entity. "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives," Swinford stated. This foundational commonality is expected to underpin the cultural integration and strategic direction of the new organization. He emphasized the unique opportunity to build upon each company’s strengths, capabilities, and passion to serve customers and patients, ultimately aiming to "help more people across their mobility journeys."
Swinford’s statement also included gracious acknowledgements to key stakeholders instrumental in Numotion’s success. He extended personal thanks to Pete Stoy for his leadership at Hanger, recognizing the strong foundation upon which the merger is built. He also expressed gratitude to AEA Investors for their "strong partnership and commitment as Numotion’s primary investor" and to LLR for its "longstanding investment in and support of the company." These acknowledgements highlight the collaborative spirit guiding the transaction and the recognition of past contributions. Looking ahead, Swinford eagerly anticipated working with teams across Hanger, Numotion, and Patient Square Capital, reiterating a "shared commitment to helping people live with greater mobility and independence." His background, including his tenure at GE Healthcare Services, provides him with a deep understanding of complex healthcare systems and the strategic acumen required to integrate and scale large organizations.
Pete Stoy on Hanger’s Transformation and Confidence in Successor
Pete Stoy, the current CEO of Hanger Inc., reflected on his accomplishments and expressed strong confidence in the future leadership of Mike Swinford. "I am incredibly proud of what our team has accomplished at Hanger and the transformation the business has undergone since I joined the company in 2020," Stoy remarked. Under his stewardship, Hanger had focused on fortifying its national platform, making significant investments in its human capital, technology infrastructure, and overall capabilities. This strategic positioning was crucial in making Hanger an attractive and capable partner for a merger of this scale, ensuring its readiness for sustained growth and expansion.
Stoy’s confidence in Swinford was unequivocal. "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction," he affirmed. He described Swinford as "an accomplished leader who shares our commitment to patients and our people," underscoring the alignment in values and strategic priorities between the two leaders. Stoy concluded by expressing his belief that Swinford is "well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead." This endorsement from the outgoing CEO is vital, providing continuity and reassurance to employees, patients, and stakeholders during a period of significant change.
Perspectives from Patient Square Capital (Implicit/Inferred)
While the provided article does not contain direct quotes from Patient Square Capital, their role as the controlling entity speaks volumes about their strategic intent. As a dedicated healthcare investment firm, Patient Square Capital’s decision to back this merger reflects a profound belief in the intrinsic value of combining Hanger’s O&P expertise with Numotion’s CRT leadership. Their objective is likely to create a dominant, vertically integrated platform that can deliver superior patient outcomes, achieve significant market share, and generate substantial long-term value. Their strategic oversight will undoubtedly focus on leveraging the synergies between the two companies, optimizing operational efficiencies, driving technological innovation, and expanding market reach. Patient Square Capital’s involvement signifies a commitment to investing in and nurturing a healthcare leader that is poised to make a profound impact on the lives of millions.
Implications and Future Outlook
The formation of Hanger Numotion carries wide-ranging implications, not only for the companies involved but also for patients, the broader healthcare industry, and the competitive landscape of mobility and rehabilitation services.
Enhanced Patient Experience and Continuum of Care
The most significant implication for patients is the promise of an enhanced and streamlined experience. By integrating O&P, CRT, and general mobility solutions, Hanger Numotion aims to create a true continuum of care. Patients who previously had to navigate separate providers, manage multiple appointments, and deal with fragmented billing systems will theoretically benefit from a more cohesive approach. This could translate into integrated medical records, coordinated treatment plans, and easier referrals between different specialized services. For example, a patient recovering from an amputation might seamlessly transition from prosthetic fitting to evaluating the need for a custom power wheelchair, all within a more unified system. This holistic approach can reduce patient burden, improve compliance, and potentially lead to better long-term functional outcomes and quality of life. The ability to offer preventative care and comprehensive long-term support will also be a key advantage.
Industry Impact and Competitive Landscape
The merger will undoubtedly reshape the competitive landscape of the North American mobility and rehabilitation market. Hanger Numotion will emerge as a dominant player, setting new benchmarks for scale, service integration, and potentially, pricing and innovation. This consolidation could put pressure on smaller, independent O&P clinics and CRT providers, who may struggle to compete with the vast resources, purchasing power, and comprehensive service offerings of the new entity. It may also spur further consolidation within the industry as other players seek to achieve similar scale or specialize in niche markets. Suppliers and manufacturers of prosthetic components, orthotic materials, and complex rehabilitation equipment will also be impacted, as Hanger Numotion’s increased purchasing volume could give it significant leverage in negotiations. This could lead to more favorable terms for the combined company or even influence product development in line with its specific needs.
Economic and Operational Synergies
From an economic perspective, the merger is expected to generate significant synergies. These include cost efficiencies through consolidated administrative functions (e.g., HR, finance, IT), optimized procurement processes due to increased purchasing power, and shared best practices across clinical and operational departments. The elimination of redundant systems and processes will contribute to operational leverage. On the revenue side, the integrated platform presents opportunities for cross-referrals and expanded service offerings. For instance, a Hanger O&P patient might be introduced to Numotion’s CRT solutions, and vice-versa, creating new avenues for growth that were previously more siloed. The sharing of operational expertise and clinical protocols across the vast network can also drive overall efficiency and quality improvements.
Regulatory Considerations and Integration Challenges
The anticipated closing date in the fourth quarter of 2026 suggests that the transaction will undergo rigorous regulatory scrutiny. Given the significant market share and geographic reach of the combined entity, antitrust regulators in both the U.S. and Canada will likely review the merger to ensure it does not unduly limit competition or harm consumers. Healthcare-specific regulations related to billing, patient data privacy (e.g., HIPAA), and professional licensing will also need careful consideration during the integration process.
Beyond regulatory hurdles, the operational integration of two large, distinct organizations presents considerable challenges. These include harmonizing diverse corporate cultures, integrating disparate IT systems (patient records, billing, inventory management), standardizing clinical protocols while preserving specialized expertise, and retaining key talent from both companies. The decision to maintain separate brands and clinical operations initially is a prudent strategy to mitigate immediate disruption, but the long-term success will hinge on effective integration planning and execution, ensuring that the best aspects of both companies are preserved and leveraged.
A New Chapter in Mobility and Independence
Ultimately, the Hanger Numotion merger represents a bold step towards a new chapter in the provision of mobility and independence solutions. By bringing together best-in-class O&P and CRT services, the combined entity aims to be more than the sum of its parts. It envisions a future where individuals with mobility challenges receive comprehensive, coordinated, and innovative care that empowers them to live fuller, more independent lives. This strategic alliance underscores a deep commitment to patient advocacy, technological advancement, and clinical excellence, positioning Hanger Numotion as a pivotal force in shaping the future of rehabilitative healthcare in North America. The journey ahead will be complex, but the potential for profound positive impact on millions of lives is immense.
